TYMS and breast carcinoma: In breast cancer-derived cell line with tetracycline-regulated expression of TS, TS overexpression confers an increased resistance to TS-targeted drugs, while the growth inhibitory effect of other drugs such as oxaliplatin is unaffected by TS upregulation (Longley et al, 2001).